Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
Key highlights from the first quarter of operations under the expanded management team include the following: Anticipated FDA decision on the Company's ANDA for Preservative-Free Ketamine in Q3 2026 ...
MarketBeat via MSN
NRx Pharmaceuticals Q1 earnings call highlights
Key Points Interested in NRx Pharmaceuticals, Inc.? Here are five stocks we like better. KETAFREE moved closer to a potential ...
Certains résultats ont été masqués, car ils peuvent vous être inaccessibles.
Afficher les résultats inaccessibles